Biblio

Author [ Title(Desc)] Type Year
Filters: Author is Bazarbachi, Ali  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Dalle, I.Abou, Nassif, S., and Bazarbachi, A. (2016). Acute promyelocytic leukemia with increased bone marrow reticulin fibrosis: Description of three cases and review of the literature.Hematol Oncol Stem Cell Ther.
B
Bazarbachi, A., Boumendil, A., Finel, H., Mohty, M., Castagna, L., Blaise, D., Peggs, K.S., Afanasyev, B., Díez-Martín, J.L., Corradini, P., et al. (2018). Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.Cancer.
C
Kansagra, A.J., Frey, N.V., Bar, M., Laetsch, T.W., Carpenter, P.A., Savani, B.N., Heslop, H.E., Bollard, C.M., Komanduri, K.V., Gastineau, D.A., et al. (2018). Clinical utilization of Chimeric Antigen Receptors T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL) - an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transpl.Biol Blood Marrow Transplant.
Atoui, A., Labban, M.El, Ghaoui, N., Darsa, H.El, Cheikh, J.El, and Bazarbachi, A. (2019). Correction: Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma.Bone Marrow Transplant.
H
Bazarbachi, A., Labopin, M., Angelucci, E., Gulbas, Z., Ozdoğu, H., Arat, M., de Rosa, L., Pastano, R., Pioltelli, P., Montserrat, R., et al. (2020). Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: a report from the EBMT acute leukemia working party.Biol Blood Marrow Transplant.
I
Bazarbachi, A., Boumendil, A., Finel, H., Castagna, L., Dominietto, A., Blaise, D., Diez-Martin, J.L., Tischer, J., Gulbas, Z., Wallet, H.L., et al. (2019). Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study.Br J Haematol.
M
Boileau, M., Shirinian, M., Gayden, T., Harutyunyan, A.S., Chen, C.C.L., Mikael, L.G., Duncan, H.M., Neumann, A.L., Arreba-Tutusaus, P., De Jay, N., et al. (2019). Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness.Nat Commun10, 2891.
P
Mohammed, J., Aljurf, M., Althumayri, A., Almansour, M., Alghamdi, A., Hamidieh, A.Ali, Elhaddad, A., Ben Othman, T., Bazarbachi, A., Almohareb, F., et al. (2019). Physical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation: Recommendations from The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group.Hematol Oncol Stem Cell Ther.
R
Cook, L.B., Fuji, S., Hermine, O., Bazarbachi, A., Ramos, J.Carlos, Ratner, L., Horwitz, S., Fields, P., Tanase, A., Bumbea, H., et al. (2019). Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.J Clin OncolJCO1800501.
T
Marçais, A., Suarez, F., Sibon, D., Frenzel, L., Hermine, O., and Bazarbachi, A. (2013). Therapeutic Options for Adult T-Cell Leukemia/Lymphoma.Curr Oncol Rep.